ScholarLens Back to search
1984•Unpublished venueRequires access

NASOPHARYNGEAL CARCINOMA AND DIFFERENT KINDS OF THE ANTIBODY TO EPSTEIN-BARR VIRUS

Shuqin Wang

Open publisher page 0 citations

Abstract

Eighty-eight sera samples from the patients with nasopharyngeal carcinoma have been examined for the antibodies: EBV-VCA IgA, EBV-VCA IgG, EBV-MA IgA and EBV-EA IgA, The positive rates for these antibodies are 85.2%, 62.5%, 63.6% and 65.9%, respectively. While 10 sera samples of normal subjects are negative for all four kinds of the antibodyWe suggest that the specificity to both antibodies of EBV-VCA IgM and EBV-MA IgA and their correlation with nasopharyngeal carcinoma should be studied further in future.

About this research paper

What this paper is about

Eighty-eight sera samples from the patients with nasopharyngeal carcinoma have been examined for the antibodies: EBV-VCA IgA, EBV-VCA IgG, EBV-MA IgA and EBV-EA IgA, The positive rates for these antibodies are 85.2%, 62.5%, 63.6% and 65.9%, respectively. While 10 sera samples of normal subjects are negative for all four kinds of the antibodyWe suggest that the specificity to both antibodies of EBV-VCA IgM and EBV-MA IgA and their correlation with nasopharyngeal carcinoma should be studied further in future.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Eighty-eight sera samples from the patients with nasopharyngeal carcinoma have been examined for the antibodies: EBV-VCA IgA, EBV-VCA IgG, EBV-MA IgA and EBV-EA IgA, The positive rates for these antibodies are 85.2%, 62.5%, 63.6% and 65.9%, respectively. While 10 sera samples of normal subjects are negative for all four kinds of the antibodyWe suggest that the specificity to both antibodies of EBV-VCA IgM and EBV-MA IgA and their correlation with nasopharyngeal carcinoma should be studied further in future.

Key concepts: Nasopharyngeal carcinoma, Epstein–Barr virus, Antibody, Virus, Carcinoma, Immunology, Immunoglobulin A, Virology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
NASOPHARYNGEAL CARCINOMA AND DIFFERENT KINDS OF THE ANTIBODY TO EPSTEIN-BARR VIRUS — Research Paper | ScholarLens